Dogwood Therapeutics (NASDAQ:DWTX) Upgraded at HC Wainwright
HC Wainwright upgraded shares of Dogwood Therapeutics (NASDAQ:DWTX – Free Report) from a neutral rating to a buy rating in a research note released on Wednesday, MarketBeat.com reports. They currently have $10.00 target price on the stock. HC Wainwright also issued estimates for Dogwood Therapeutics’ Q1 2025 earnings at ($0.48) EPS, Q2 2025 earnings at […]
HC Wainwright upgraded shares of Dogwood Therapeutics (NASDAQ:DWTX – Free Report) from a neutral rating to a buy rating in a research note released on Wednesday, MarketBeat.com reports. They currently have $10.00 target price on the stock. HC Wainwright also issued estimates for Dogwood Therapeutics’ Q1 2025 earnings at ($0.48) EPS, Q2 2025 earnings at […]
